Ibex Medical Analytics: Business Overview, Financials & Competitive Analysis
Ibex Medical Analytics scores 7/10 on the AskCyborg Cyborg Score (Strong). Clinical-grade AI cancer diagnostics with proven market adoption, strong venture backing, and expanding global deployment position Ibex as a leading contender in AI-powered pathology. The company raised $55 million in Series C funding in September 2023, led by 83NORTH and including Sienna Venture Capital and existing investors Octopus Ventures.
What is Ibex Medical Analytics's industry? Ibex Medical Analytics (ibex.ai) operates in Digital Health. AskCyborg classifies Ibex Medical Analytics under Digital Health in its company registry.
Ibex Medical Analytics develops AI-based diagnostics technology designed to improve clinical decision-making and streamline pathology laboratory workflows, combining artificial intelligence, data science, image analys...
Cyborg Score thesis
Clinical-grade AI cancer diagnostics with proven market adoption, strong venture backing, and expanding global deployment...
Read the full analyst-debate transcript →Get the Latest Ibex Medical Analytics Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeIbex Medical Analytics Overview
Pro stress-test →Ibex Medical Analytics develops AI-based diagnostics technology designed to improve clinical decision-making and streamline pathology laboratory workflows, combining artificial intelligence, data science, image analysis, and machine-learning technologies to reveal underlying patterns and extract valuable clinical insights from digitized glass slides and electronic medical records. The company was founded with a focus on applying artificial intelligence to medicine, particularly advancing cancer care.
Strategic Profile
Pro stress-test →The company has developed the GALEN platform for treatment diagnosis and planning, plus products such as First Read and Second Read that use AI technology for cancer diagnosis based on pathological image analysis. Ibex's AI algorithms are developed from rich datasets extracted from over 10 million slides from multiple pathology institutes and are trained by teams of expert pathologists using deep learning technologies.
Competitive Landscape
Pro stress-test →Ibex's top competitors include PAIGE, Aignostics and Onc.ai. Other notable competitors in AI-powered pathology include PathAI, Proscia, Mindpeak, and Ellogon.AI. Ibex differentiates through early market entry, broad international deployment, clinical validation, and a comprehensive product portfolio spanning multiple cancer types.
Industry Context
Ibex Medical Analytics operates in Digital Health.
Key facts
Founded: 2016 · Headquarters: Ramat Gan, Israel · Employees: 105 · Revenue: $15.8M